By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ocular Therapeutix, Inc. 

204 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236



Company News
Ocular Therapeutix (OCUL) Strengthens Management Team With The Appointment Of Andy Hurley As Chief Commercial Officer 10/20/2016 11:05:52 AM
Ocular Therapeutix (OCUL) Outlines Development Strategy For Its Sustained Release Intravitreal Depots To Address Serious Retinal Diseases 10/13/2016 12:39:07 PM
Regeneron (REGN) Bets $315 Million on Ocular Therapeutix (OCUL) for an Upgraded Form of Eylea 10/13/2016 5:30:27 AM
Ocular Therapeutix (OCUL) Begins Enrollment In First Phase 3 Clinical Trial With OTX-TP (Sustained Release Travoprost) For The Treatment Of Glaucoma And Ocular Hypertension 10/5/2016 10:53:36 AM
Ocular Therapeutix (OCUL) To Participate In The Morgan Stanley Global Healthcare Conference 9/1/2016 11:37:04 AM
Ocular Therapeutix (OCUL) Reports Second Quarter 2016 Financial Results And Provides Corporate Update 8/9/2016 11:08:41 AM
Ocular Therapeutix (OCUL) Provides Update On NDA For DEXTENZA For The Treatment Of Post-Surgical Ocular Pain 8/4/2016 9:47:33 AM
Ocular Therapeutix (OCUL) To Report Second Quarter 2016 Financial Results 8/3/2016 10:39:00 AM
FDA Spurns Ocular Therapeutix (OCUL)'s Post-Operative Eye Pain Treatment 7/25/2016 10:59:51 AM
Ocular Therapeutix (OCUL) To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference 7/6/2016 9:15:25 AM